DAVID A. DODD - Corporate Board Profile

GeoVax Labs, Inc.

Filing Date	Source Excerpt
2010-07-09	Mr. Dodd has more than 35 years of executive experience in the healthcare industry. He was President, Chief Executive Officer and Chairman of BioReliance Corporation, and held other executive roles in pharmaceutical companies.
2011-07-06	He is the Chief Executive Officer of RiversEdge BioVentures, an investment and advisory firm focused on the life sciences and pharmaceuticals industries, which he founded in 2009. He has more than 35 years of executive experience in the healthcare industry.
2012-04-26	Mr. Dodd is the Chief Executive Officer of RiversEdge BioVentures, an investment and advisory firm focused on the life sciences and pharmaceuticals industries... The Board of Directors concluded Mr. Dodd should serve on the Board of Directors due to his experience in the pharmaceutical industry, as well as his background in general management, business transformation, corporate partnering, and mergers and acquisitions.
2013-04-23	He has more than 35 years of executive experience in the healthcare industry. From December 2007 to June 2009, Mr. Dodd was President, Chief Executive Officer and Chairman of BioReliance Corporation, a leading provider of biological safety and related testing services.
2014-04-30	He has more than 35 years of executive experience in the healthcare industry... The Board of Directors concluded Mr. Dodd should serve on the Board of Directors due to his experience in the pharmaceutical industry, as well as his background in general management, business transformation, corporate partnering, and mergers and acquisitions.
2015-03-31	He has more than 35 years of executive experience in the healthcare industry. From December 2007 to June 2009, Mr. Dodd was President, Chief Executive officer and Chairman of BioReliance Corporation, an organization that provided biological safety testing, viral clearance testing, genetic and mammalian technology testing and laboratory animal diagnostic services testing.
2016-04-29	Mr. Dodd has more than 35 years of executive experience in the healthcare industry, including leadership roles in pharmaceutical companies.
2017-04-26	Mr. Dodd has more than 35 years of executive experience in the healthcare industry, including leadership roles in pharmaceutical companies.
2017-06-16	David A. Dodd (4) 265,791 *
2018-04-27	He has more than 35 years of executive experience in the healthcare industry. From December 2007 to June 2009, Mr. Dodd was President, Chief Executive officer and Chairman of BioReliance Corporation, an organization that provided biological safety testing, viral clearance testing, genetic and mammalian technology testing and laboratory animal diagnostic services testing.
2019-03-01	David A. Dodd (4) 3,519,325 1.3 %
2019-12-02	David A. Dodd (4) 7,878 * Includes options to purchase 7,622 shares of Common Stock exercisable within 60 days of November 21, 2019.
2020-07-07	His executive management experience in the pharmaceutical and biotechnology industries spans more than 40 years. ... The Board of Directors has concluded that Mr. Dodd should serve on the Board of Directors due to his experience in the pharmaceutical industry and his involvement as an officer and director of the Company, as well as his background in general management, business transformation, corporate partnering, and mergers and acquisitions.
2021-06-21	His executive management experience in the pharmaceutical and biotechnology industries spans more than 40 years. ... The Board of Directors has concluded that Mr. Dodd should serve on the Board of Directors due to his experience in the pharmaceutical industry and his involvement as an officer and director of the Company, as well as his background in general management, business transformation, corporate partnering, and mergers and acquisitions.
2022-06-13	His executive management experience in the pharmaceutical and biotechnology industries spans more than 40 years. ... Mr. Dodd holds Bachelor of Science and Master of Science degrees from Georgia State University and completed the Harvard Business School Advanced Management Program.
2023-06-12	Mr. Dodd holds Bachelor of Science and Master of Science degrees from Georgia State University and completed the Harvard Business School Advanced Management Program. The Board of Directors has concluded that Mr. Dodd should serve on the Board of Directors due to his experience in the pharmaceutical industry and his involvement as an officer and director of the Company, as well as his background in general management, business transformation, corporate partnering, and mergers and acquisitions.
2024-04-15	His executive management experience in the pharmaceutical and biotechnology industries spans more than 40 years. ... The Board of Directors has concluded that Mr. Dodd should serve on the Board of Directors due to his experience in the pharmaceutical industry and his involvement as an officer and director of the Company, as well as his background in general management, business transformation, corporate partnering, and mergers and acquisitions.